Role of Myelin-Associated Glycoprotein (Siglec-4a) in the Nervous System

Chapter
Part of the Advances in Neurobiology book series (NEUROBIOL, volume 9)

Abstract

Myelin-associated glycoprotein (MAG) is a 100 kDa glycoprotein located at the innermost layer of myelin sheets that remains in intimate contact with the axonal membrane. It is selectively expressed by myelinating cells including Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS). Due to its selective location and its effects on neurons, it was originally thought to be involved in axon–glia communication. The generation of MAG-deficient mice greatly expanded our knowledge about the physiological role of MAG, which helped to establish its critical roles in the normal formation and maintenance of myelinated axons. Interest in MAG was revived when it was described as the first myelin-derived inhibitor of axon regeneration. Since then numerous publications have provided detailed information about its axonal receptors and their signaling pathways. Recently, the nurture role of MAG on neurons was confirmed. On the other hand, MAG mediates signals coming from the axons that strongly impact on oligodendrocytes and Schwann cells, highlighting the bidirectional nature of axon–glia communication. Overall, MAG is a critical component of axon–glia interactions with multiple functions in the biology of both neurons and glial cells.

Keywords

MAG Myelin-associated glycoprotein Siglec-4a (sialic acid-binding immunoglobulin-type lectin 4a) Myelin Axon–glia interaction Oligodendrocyte Schwann cell Axon regeneration Neuroprotection Gangliosides NgR (Nogo-66 receptor) 

Notes

References

  1. Afar DE, Salzer JL, Roder J, Braun PE, Bell JC. Differential phosphorylation of myelin-associated glycoprotein isoforms in cell culture. J Neurochem. 1990;55(4):1418–26.PubMedGoogle Scholar
  2. Agrawal HC, Noronha AB, Agrawal D, Quarles RH. The myelin-associated glycoprotein is phosphorylated in the peripheral nervous system. Biochem Biophys Res Commun. 1990;169(3):953–8.PubMedGoogle Scholar
  3. Ahmed Z, Douglas MR, John G, Berry M, Logan A. AMIGO3 is an NgR1/p75 co-receptor signalling axon growth inhibition in the acute phase of adult central nervous system injury. PLoS One. 2013;8(4):e61878.PubMedCentralPubMedGoogle Scholar
  4. Arquint M, Roder J, Chia LS, Down J, Wilkinson D, Bayley H, et al. Molecular cloning and primary structure of myelin-associated glycoprotein. Proc Natl Acad Sci U S A. 1987;84(2):600–4.PubMedCentralPubMedGoogle Scholar
  5. Attia J, Hicks L, Oikawa K, Kay CM, Dunn RJ. Structural properties of the myelin-associated glycoprotein ectodomain. J Neurochem. 1993;61(2):718–26.PubMedGoogle Scholar
  6. Attia J, Tropak M, Johnson PW, Newerly-Abranow W, Pawson T, Roder JC et al. Modulated adhesion: a proposal for the role of myelin-associated glycoprotein in myelin wrapping. Clin Chem. 1989;35(5):717–20. Review.PubMedGoogle Scholar
  7. Atwal JK, Pinkston-Gosse J, Syken J, Stawicki S, Wu Y, Shatz C, et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science. 2008;322(5903):967–70.PubMedGoogle Scholar
  8. Bartsch U, Bandtlow CE, Schnell L, Bartsch S, Spillmann AA, Rubin BP, et al. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron. 1995;15(6):1375–81.PubMedGoogle Scholar
  9. Biffiger K, Bartsch S, Montag D, Aguzzi A, Schachner M, Bartsch U. Severe hypomyelination of the murine CNS in the absence of myelin-associated glycoprotein and fyn tyrosine kinase. J Neurosci. 2000;20(19):7430–7.PubMedGoogle Scholar
  10. Cafferty WB, Duffy P, Huebner E, Strittmatter SM. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci. 2010;30(20):6825–37.PubMedCentralPubMedGoogle Scholar
  11. Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci. 2001;21(13):4731–9.PubMedGoogle Scholar
  12. Cao Z, Qiu J, Domeniconi M, Hou J, Bryson JB, Mellado W, et al. The inhibition site on myelin-associated glycoprotein is within Ig-domain 5 and is distinct from the sialic acid binding site. J Neurosci. 2007;27(34):9146–54.PubMedGoogle Scholar
  13. Crocker PR, Clark EA, Filbin M, Gordon S, Jones Y, Kehrl JH, et al. Siglecs: a family of sialic-acid binding lectins. Glycobiology. 1998;8(2):v.PubMedGoogle Scholar
  14. Dashiell SM, Tanner SL, Pant HC, Quarles RH. Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. J Neurochem. 2002;81(6):1263–72.PubMedGoogle Scholar
  15. Dickendesher TL, Baldwin KT, Mironova YA, Koriyama Y, Raiker SJ, Askew KL, et al. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat Neurosci. 2012;15(5):703–12.PubMedCentralPubMedGoogle Scholar
  16. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 2002;35(2):283–90.PubMedGoogle Scholar
  17. Domeniconi M, Zampieri N, Spencer T, Hilaire M, Mellado W, Chao MV, et al. MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron. 2005;46(6):849–55.PubMedGoogle Scholar
  18. Dulac C, Tropak MB, Cameron-Curry P, Rossier J, Marshak DR, Roder J, et al. Molecular characterization of the Schwann cell myelin protein, SMP: structural similarities within the immunoglobulin superfamily. Neuron. 1992;8(2):323–34.PubMedGoogle Scholar
  19. Edwards AM, Arquint M, Braun PE, Roder JC, Dunn RJ, Pawson T, et al. Myelin-associated glycoprotein, a cell adhesion molecule of oligodendrocytes, is phosphorylated in brain. Mol Cell Biol. 1988;8(6):2655–8.PubMedCentralPubMedGoogle Scholar
  20. Edwards AM, Braun PE, Bell JC. Phosphorylation of myelin-associated glycoprotein in vivo and in vitro occurs only in the cytoplasmic domain of the large isoform. J Neurochem. 1989;52(1):317–20.PubMedGoogle Scholar
  21. Erb M, Flueck B, Kern F, Erne B, Steck AJ, Schaeren-Wiemers N. Unraveling the differential expression of the two isoforms of myelin-associated glycoprotein in a mouse expressing GFP-tagged S-MAG specifically regulated and targeted into the different myelin compartments. Mol Cell Neurosci. 2006;31(4):613–27.PubMedGoogle Scholar
  22. Everly JL, Brady RO, Quarles RH. Evidence that the major protein in rat sciatic nerve myelin is a glycoprotein. J Neurochem. 1973;21(2):329–34.PubMedGoogle Scholar
  23. Frail DE, Braun PE. Two developmentally regulated messenger RNAs differing in their coding region may exist for the myelin-associated glycoprotein. J Biol Chem. 1984;259(23):14857–62.PubMedGoogle Scholar
  24. Franzen R, Tanner SL, Dashiell SM, Rottkamp CA, Hammer JA, Quarles RH. Microtubule-associated protein 1B: a neuronal binding partner for myelin-associated glycoprotein. J Cell Biol. 2001;155(6):893–8.PubMedCentralPubMedGoogle Scholar
  25. Fruttiger M, Montag D, Schachner M, Martini R. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci. 1995;7(3):511–5.PubMedGoogle Scholar
  26. Fujita N, Kemper A, Dupree J, Nakayasu H, Bartsch U, Schachner M, et al. The cytoplasmic domain of the large myelin-associated glycoprotein isoform is needed for proper CNS but not peripheral nervous system myelination. J Neurosci. 1998;18(6):1970–8.PubMedGoogle Scholar
  27. Fujita Y, Endo S, Takai T, Yamashita T. Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. EMBO J. 2011a;30(7):1389–401.PubMedCentralPubMedGoogle Scholar
  28. Fujita Y, Takashima R, Endo S, Takai T, Yamashita T. The p75 receptor mediates axon growth inhibition through an association with PIR-B. Cell Death Dis. 2011b;2:e198.PubMedCentralPubMedGoogle Scholar
  29. Georgiou J, Charlton MP. Non-myelin-forming perisynaptic schwann cells express protein zero and myelin-associated glycoprotein. Glia. 1999;27(2):101–9.PubMedGoogle Scholar
  30. Goh EL, Young JK, Kuwako K, Tessier-Lavigne M, He Z, Griffin JW, et al. Beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones. Mol Brain. 2008;1:10.PubMedCentralPubMedGoogle Scholar
  31. Hasegawa Y, Fujitani M, Hata K, Tohyama M, Yamagishi S, Yamashita T. Promotion of axon regeneration by myelin-associated glycoprotein and Nogo through divergent signals downstream of Gi/G. J Neurosci. 2004;24(30):6826–32.PubMedGoogle Scholar
  32. Hayakawa T, Angata T, Lewis AL, Mikkelsen TS, Varki NM, Varki A. A human-specific gene in microglia. Science. 2005;309(5741):1693.PubMedGoogle Scholar
  33. Hsieh SH, Ferraro GB, Fournier AE. Myelin-associated inhibitors regulate cofilin phosphorylation and neuronal inhibition through LIM kinase and Slingshot phosphatase. J Neurosci. 2006;26(3):1006–15.PubMedGoogle Scholar
  34. Inuzuka T, Fujita N, Sato S, Baba H, Nakano R, Ishiguro H, et al. Expression of the large myelin-associated glycoprotein isoform during the development in the mouse peripheral nervous system. Brain Res. 1991;562(1):173–5.PubMedGoogle Scholar
  35. Irving EA, Vinson M, Rosin C, Roberts JC, Chapman DM, Facci L, et al. Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? J Cereb Blood Flow Metab. 2005;25(1):98–107.PubMedGoogle Scholar
  36. Ishiguro H, Sato S, Fujita N, Inuzuka T, Nakano R, Miyatake T. Immunohistochemical localization of myelin-associated glycoprotein isoforms during the development in the mouse brain. Brain Res. 1991;563(1–2):288–92.PubMedGoogle Scholar
  37. Jaramillo ML, Afar DE, Almazan G, Bell JC. Identification of tyrosine 620 as the major phosphorylation site of myelin-associated glycoprotein and its implication in interacting with signaling molecules. J Biol Chem. 1994;269(44):27240–5.PubMedGoogle Scholar
  38. Johnson PW, Bramow-Newerly W, Seilheimer B, Sadoul R, Tropak MB, Arquint M, et al. Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function. Neuron. 1989;3(3):377–85.PubMedGoogle Scholar
  39. Jones MV, Nguyen TT, Ewaleifoh O, Lebson L, Whartenby KA, Griffin JW, et al. Accelerated axon loss in MOG35-55 experimental autoimmune encephalomyelitis (EAE) in myelin-associated glycoprotein-deficient (MAGKO) mice. J Neuroimmunol. 2013;262(1–2):53–61.PubMedGoogle Scholar
  40. Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, de Bellard ME, et al. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol. 1994;4(11):965–72.PubMedGoogle Scholar
  41. Kirchhoff F, Hofer HW, Schachner M. Myelin-associated glycoprotein is phosphorylated by protein kinase C. J Neurosci Res. 1993;36(4):368–81.PubMedGoogle Scholar
  42. Kramer-Albers EM, White R. From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell Mol Life Sci. 2011;68(12):2003–12.PubMedGoogle Scholar
  43. Kursula P, Lehto VP, Heape AM. The small myelin-associated glycoprotein binds to tubulin and microtubules. Brain Res Mol Brain Res. 2001;87(1):22–30.PubMedGoogle Scholar
  44. Kursula P, Lehto VP, Heape AM. S100beta inhibits the phosphorylation of the L-MAG cytoplasmic domain by PKA. Brain Res Mol Brain Res. 2000;76(2):407–10.PubMedGoogle Scholar
  45. Kursula P, Merilainen G, Lehto VP, Heape AM. The small myelin-associated glycoprotein is a zinc-binding protein. J Neurochem. 1999a;73(5):2110–8.PubMedGoogle Scholar
  46. Kursula P, Tikkanen G, Lehto VP, Nishikimi M, Heape AM. Calcium-dependent interaction between the large myelin-associated glycoprotein and S100beta. J Neurochem. 1999b;73(4):1724–32.PubMedGoogle Scholar
  47. Lai C, Brow MA, Nave KA, Noronha AB, Quarles RH, Bloom FE, et al. Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proc Natl Acad Sci U S A. 1987;84(12):4337–41.PubMedCentralPubMedGoogle Scholar
  48. Lassmann H, Bartsch U, Montag D, Schachner M. Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency. Glia. 1997;19(2):104–10.PubMedGoogle Scholar
  49. Lauren J, Hu F, Chin J, Liao J, Airaksinen MS, Strittmatter SM. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members. J Biol Chem. 2007;282(8):5715–25.PubMedCentralPubMedGoogle Scholar
  50. Lee JK, Geoffroy CG, Chan AF, Tolentino KE, Crawford MJ, Leal MA, et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron. 2010;66(5):663–70.PubMedCentralPubMedGoogle Scholar
  51. Li C, Tropak MB, Gerlai R, Clapoff S, Bramow-Newerly W, Trapp B, et al. Myelination in the absence of myelin-associated glycoprotein. Nature. 1994;369(6483):747–50.PubMedGoogle Scholar
  52. Liu BP, Fournier A, GrandPre T, Strittmatter SM. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 2002;297(5584):1190–3.PubMedGoogle Scholar
  53. Lopez PH, Ahmad AS, Mehta NR, Toner M, Rowland EA, Zhang J, et al. Myelin-associated glycoprotein protects neurons from excitotoxicity. J Neurochem. 2011;116(5):900–8.PubMedCentralPubMedGoogle Scholar
  54. Lunn MP, Crawford TO, Hughes RA, Griffin JW, Sheikh KA. Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing. Brain. 2002;125(Pt 4):904–11.PubMedGoogle Scholar
  55. Marcus J, Dupree JL, Popko B. Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions. J Cell Biol. 2002;156(3):567–77.PubMedCentralPubMedGoogle Scholar
  56. Marta CB, Taylor CM, Cheng S, Quarles RH, Bansal R, Pfeiffer SE. Myelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes. Neuron Glia Biol. 2004;1(1):35–46.PubMedCentralPubMedGoogle Scholar
  57. Matthieu JM, Everly JL, Brady RO, Quarles RH. [35-S]sulfate incorporation into myelin clycoproteins; II. Peripheral nervous tissue. Biochim Biophys Acta. 1975;392(1):167–74.PubMedGoogle Scholar
  58. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 1994;13(4):805–11.PubMedGoogle Scholar
  59. Mehta NR, Lopez PH, Vyas AA, Schnaar RL. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J Biol Chem. 2007;282(38):27875–86.PubMedCentralPubMedGoogle Scholar
  60. Mehta NR, Nguyen T, Bullen Jr JW, Griffin JW, Schnaar RL. Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism. ACS Chem Neurosci. 2010;1(3):215–22.PubMedCentralPubMedGoogle Scholar
  61. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci. 2004;7(3):221–8.PubMedGoogle Scholar
  62. Milward E, Kim KJ, Szklarczyk A, Nguyen T, Melli G, Nayak M, et al. Cleavage of myelin associated glycoprotein by matrix metalloproteinases. J Neuroimmunol. 2008;193(1–2):140–8.PubMedCentralPubMedGoogle Scholar
  63. Mimura F, Yamagishi S, Arimura N, Fujitani M, Kubo T, Kaibuchi K, et al. Myelin-associated glycoprotein inhibits microtubule assembly by a Rho-kinase-dependent mechanism. J Biol Chem. 2006;281(23):15970–9.PubMedGoogle Scholar
  64. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Bluthmann H, et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron. 1994;13(1):229–46.PubMedGoogle Scholar
  65. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 1994;13(3):757–67.PubMedGoogle Scholar
  66. Nagai J, Goshima Y, Ohshima T. CRMP4 mediates MAG-induced inhibition of axonal outgrowth and protection against Vincristine-induced axonal degeneration. Neurosci Lett. 2012;519(1):56–61.PubMedGoogle Scholar
  67. Nguyen T, Mehta NR, Conant K, Kim KJ, Jones M, Calabresi PA, et al. Axonal protective effects of the myelin-associated glycoprotein. J Neurosci. 2009;29(3):630–7.PubMedCentralPubMedGoogle Scholar
  68. Niederost B, Oertle T, Fritsche J, McKinney RA, Bandtlow CE. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci. 2002;22(23):10368–76.PubMedGoogle Scholar
  69. Noronha AB, Hammer JA, Lai C, Kiel M, Milner RJ, Sutcliffe JG et al. Myelin-associated glycoprotein (MAG) and rat brain-specific 1B236 protein: mapping of epitopes and demonstration of immunological identity. J Mol Neurosci. 1989;1(3):159–70.PubMedGoogle Scholar
  70. Owens GC, Bunge RP. Evidence for an early role for myelin-associated glycoprotein in the process of myelination. Glia. 1989;2(2):119–28.PubMedGoogle Scholar
  71. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, et al. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol. 2005;195(1):208–17.PubMedCentralPubMedGoogle Scholar
  72. Park JB, Yiu G, Kaneko S, Wang J, Chang J, He XL, et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron. 2005;45(3):345–51.PubMedGoogle Scholar
  73. Pedraza L, Owens GC, Green LA, Salzer JL. The myelin-associated glycoproteins: membrane disposition, evidence of a novel disulfide linkage between immunoglobulin-like domains, and posttranslational palmitylation. J Cell Biol. 1990;111(6 Pt 1):2651–61.PubMedGoogle Scholar
  74. Pernet V, Joly S, Christ F, Dimou L, Schwab ME. Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci. 2008;28(29):7435–44.PubMedGoogle Scholar
  75. Quarles RH. Myelin-associated glycoprotein in development and disease. Dev Neurosci. 1983;6(6):285–303.PubMedGoogle Scholar
  76. Reimer MM, McQueen J, Searcy L, Scullion G, Zonta B, Desmazieres A, et al. Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion. J Neurosci. 2011;31(49):18185–94.PubMedGoogle Scholar
  77. Robak LA, Venkatesh K, Lee H, Raiker SJ, Duan Y, Lee-Osbourne J, et al. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition. J Neurosci. 2009;29(18):5768–83.PubMedCentralPubMedGoogle Scholar
  78. Saha N, Kolev MV, Semavina M, Himanen J, Nikolov DB. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1. Biochem Biophys Res Commun. 2011;413(1):92–7.PubMedGoogle Scholar
  79. Salzer JL, Holmes WP, Colman DR. The amino acid sequences of the myelin-associated glycoproteins: homology to the immunoglobulin gene superfamily. J Cell Biol. 1987;104(4):957–65.PubMedGoogle Scholar
  80. Sanchez I, Hassinger L, Paskevich PA, Shine HD, Nixon RA. Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J Neurosci. 1996;16(16):5095–105.PubMedGoogle Scholar
  81. Sato S, Quarles RH, Brady RO. Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J Neurochem. 1982;39(1):97–105.PubMedGoogle Scholar
  82. Schafer M, Fruttiger M, Montag D, Schachner M, Martini R. Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron. 1996;16(6):1107–13.PubMedGoogle Scholar
  83. Schnaar RL, Lopez PH. Myelin-associated glycoprotein and its axonal receptors. J Neurosci Res. 2009;87(15):3267–76.PubMedCentralPubMedGoogle Scholar
  84. Sgroi D, Nocks A, Stamenkovic I. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33. J Biol Chem. 1996; 271(31):18803–9.PubMedGoogle Scholar
  85. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, et al. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron. 2005;45(3):353–9.PubMedGoogle Scholar
  86. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, et al. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A. 1999;96(13):7532–7.PubMedCentralPubMedGoogle Scholar
  87. Song H, Ming G, He Z, Lehmann M, McKerracher L, Tessier-Lavigne M, et al. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science. 1998;281(5382):1515–8.PubMedGoogle Scholar
  88. Stiles TL, Dickendesher TL, Gaultier A, Fernandez-Castaneda A, Mantuano E, Giger RJ, et al. LDL receptor-related protein-1 is a sialic-acid-independent receptor for myelin-associated glycoprotein that functions in neurite outgrowth inhibition by MAG and CNS myelin. J Cell Sci. 2013;126(Pt 1):209–20.PubMedCentralPubMedGoogle Scholar
  89. Tang S, Shen YJ, DeBellard ME, Mukhopadhyay G, Salzer JL, Crocker PR, et al. Myelin-associated glycoprotein interacts with neurons via a sialic acid binding site at ARG118 and a distinct neurite inhibition site. J Cell Biol. 1997a;138(6):1355–66.PubMedCentralPubMedGoogle Scholar
  90. Tang S, Woodhall RW, Shen YJ, DeBellard ME, Saffell JL, Doherty P, et al. Soluble myelin-associated glycoprotein (MAG) found in vivo inhibits axonal regeneration. Mol Cell Neurosci. 1997b;9(5–6):333–46.PubMedGoogle Scholar
  91. Trapp BD, Andrews SB, Cootauco C, Quarles R. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J Cell Biol. 1989;109(5):2417–26.PubMedGoogle Scholar
  92. Trapp BD, Quarles RH. Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol. 1982;92(3):877–82.PubMedGoogle Scholar
  93. Tropak MB, Johnson PW, Dunn RJ, Roder JC. Differential splicing of MAG transcripts during CNS and PNS development. Brain Res. 1988;464(2):143–55.PubMedGoogle Scholar
  94. Tropak MB, Roder JC. Regulation of myelin-associated glycoprotein binding by sialylated cis-ligands. J Neurochem. 1997;68(4):1753–63.PubMedGoogle Scholar
  95. Umemori H, Sato S, Yagi T, Aizawa S, Yamamoto T. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature. 1994;367(6463):572–6.PubMedGoogle Scholar
  96. Uschkureit T, Sporkel O, Stracke J, Bussow H, Stoffel W. Early onset of axonal degeneration in double (plp-/-mag-/-) and hypomyelinosis in triple (plp-/-mbp-/-mag-/-) mutant mice. J Neurosci. 2000;20(14):5225–33.PubMedGoogle Scholar
  97. Venkatesh K, Chivatakarn O, Lee H, Joshi PS, Kantor DB, Newman BA, et al. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J Neurosci. 2005;25(4):808–22.PubMedGoogle Scholar
  98. Venkatesh K, Chivatakarn O, Sheu SS, Giger RJ. Molecular dissection of the myelin-associated glycoprotein receptor complex reveals cell type-specific mechanisms for neurite outgrowth inhibition. J Cell Biol. 2007;177(3):393–9.PubMedCentralPubMedGoogle Scholar
  99. Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, et al. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A. 2002;99(12):8412–7.PubMedCentralPubMedGoogle Scholar
  100. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature. 2002;420(6911):74–8.PubMedGoogle Scholar
  101. Wang X, Mitra N, Cruz P, Deng L, Varki N, Angata T, et al. Evolution of siglec-11 and siglec-16 genes in hominins. Mol Biol Evol. 2012;29(8):2073–86.PubMedCentralPubMedGoogle Scholar
  102. Weiss MD, Hammer J, Quarles RH. Oligodendrocytes in aging mice lacking myelin-associated glycoprotein are dystrophic but not apoptotic. J Neurosci Res. 2000;62(6):772–80.PubMedGoogle Scholar
  103. Weiss MD, Luciano CA, Quarles RH. Nerve conduction abnormalities in aging mice deficient for myelin-associated glycoprotein. Muscle Nerve. 2001;24(10):1380–7.PubMedGoogle Scholar
  104. Williams G, Wood A, Williams EJ, Gao Y, Mercado ML, Katz A, et al. Ganglioside inhibition of neurite outgrowth requires Nogo receptor function: identification of interaction sites and development of novel antagonists. J Biol Chem. 2008;283(24):16641–52.PubMedGoogle Scholar
  105. Wong EV, David S, Jacob MH, Jay DG. Inactivation of myelin-associated glycoprotein enhances optic nerve regeneration. J Neurosci. 2003;23(8):3112–7.PubMedGoogle Scholar
  106. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci. 2002;5(12):1302–8.PubMedGoogle Scholar
  107. Xie W, Uchida H, Nagai J, Ueda M, Chun J, Ueda H. Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain. J Neurochem. 2010;113(4):1002–11.PubMedCentralPubMedGoogle Scholar
  108. Yang LJ, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, et al. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci U S A. 1996;93(2):814–8.PubMedCentralPubMedGoogle Scholar
  109. Yim SH, Quarles RH. Biosynthesis and expression of the myelin-associated glycoprotein in cultured oligodendrocytes from adult bovine brain. J Neurosci Res. 1992; 33(3):370–8.PubMedGoogle Scholar
  110. Yim SH, Toda K, Goda S, Quarles RH. Comparison of the phosphorylation of myelin-associated glycoprotein in cultured oligodendrocytes and Schwann cells. J Mol Neurosci. 1995;6(1):63–74.PubMedGoogle Scholar
  111. Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C, et al. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci. 1998;18(6):1953–62.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Laboratorio de Neurobiología, Instituto de Investigación Médica Mercedes y Martín FerreyraINIMEC-CONICET-Universidad Nacional de CórdobaCórdobaArgentina
  2. 2.Facultad de PsicologíaUniversidad Nacional de CórdobaCórdobaArgentina

Personalised recommendations